TIMP1 and central nervous system cancer: These results show that TIMP1 is more highly expressed and that the degree of TIMP1 promoter methylation was much lower in IDH-WT gliomas than in IDH-Mut gliomas; this promoter can also act as a prognostic biomarker for glioma.